The Investigation of the Oxidative Stress-Related Parameters in Type2 Diabetes Mellitus

Canadian Journal of Diabetes

Volumn 39, Issue 1, 2015, Pages 44-49

  Aouacheri, Ouassila ^a   Saka, Saad ^a   Krim, Meriem ^a   Messaadia, Amira ^a   Maidi, Imen ^a  

^a BADJI MOKHTAR UNIVERSITY   (Algeria)

Author keywords

Glutathione peroxidase; Glutathione reductase; Malondialdehyde; Oxidative stress; Superoxide dismutase; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN A1C; MALONALDEHYDE; OXIDATIVE STRESS MARKER; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; REACTIVE OXYGEN METABOLITE;

ADULT; ALGERIAN; ARTICLE; BLOOD ANALYSIS; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN CONTENT; BLOOD; HYPERGLYCEMIA; LIPID PEROXIDATION; METABOLISM;

ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84921354808     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2014.03.002     Document Type: Article

References (50)

1. Dawud F.A., Eze E.D., Ardja A.A., et al. Ameliorative effects of vitamin C and zinc in alloxan-induced diabetes and oxidative stress in Wistar rats. Curr Res J Biol Sci 2012, 4:123-129.
2. Matough F.A., Budin S.B., Hamid Z.A., et al. The role of oxidative stress and antioxidants in diabetes complications. Sultan Qaboos Univ J 2012, 12:5-18.
3. Rosin D., Sapna L.S. Supplementation effects of vitamin C and vitamin E on oxidative stress in post menopausal diabetes women. JAppl Res 2012, 12:108-111.
4. Eiselein L., Schwartz H.J., Rutledge J.C. The challenge of type 1 diabetes mellitus. ILAR J 2004, 45:231-236.
5. Kolluru G.K., Bir S.C., Kevil C.G. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012, 2012:1-30.
6. Góth L., Nagy T. Acatalasemia and diabetes mellitus. Arch Biochem Biophys 2012, 525:195-200.
7. Song F., Jia W., Yao Y., et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes. Clin Sci 2007, 112:599-606.
8. Ovalle F., Garvey W.T. Type 2 diabetes mellitus. Encyclopedia of endocrine diseases 2004, 546-566. Academic Press/Elsevier Science, Burlington. L. Martini, M.A. Burlington (Eds.).
9. Mealey B.L., Ocampo G.L. Diabetes mellitus and periodontal disease. Periodontology 2000 2007, 44:127-153.
10. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetes vascular disease. Bratisl Lek Listy 2000, 101:541-551.
11. Mohora M., Greabu M., Muscurel C., et al. The sources and the targets of oxidative stress in the etiology of diabetes complications. Romanian J Biophys 2007, 17:63-84.
12. Small D.M., Coombes J.S., Bennett N., et al. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology 2012, 17:311-321.
13. Kassab A., Piwowar A. Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie 2012, 94:1837-1848.
14. Kajimoto Y., Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann NY Acad Sci 2004, 1011:168-176.
15. Giacco F., Brownlee M. Oxidative stress and diabetes complications. Circ Res 2010, 107:1058-1070.
16. Pan H.Z., Zhang L., Guo M.Y., et al. The oxidative stress status in diabetes mellitus and diabetes nephropathy. Acta Diabetol 2010, 47:71-76.
17. Odum E.P., Ejilemele A.A., Wakwe V.C. Antioxidant status of type 2 diabetic patients in Port Harcourt, Nigeria. Niger J Clin Pract 2012, 15:55-58.
18. Shi Y.C., Pan T.M. Red mold, diabetes, and oxidative stress: A review. Appl Microbiol Biotechnol 2012, 94:47-55.
19. Lima V.B.S., Sampaio F.A., Bezerra D.L.C., et al. Parameters of glycemic control and their relationship with zinc concentrations in blood and with superoxide dismutase enzyme activity in type 2 diabetes patients. Arq Bras Endocrinol Metab 2011, 55:701-707.
20. Likidlilid A., Patchanans N., Peerapatdit T., et al. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetes patients. JMed Assoc Thai 2010, 93:682-693.
21. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diab Res Clin Pract 2011, 94:311-321.
22. Esterbauer H., Gebicki J., Puhl H., et al. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992, 13:341-390.
23. Weckbecker G., Cory J.G. Ribonucleotide reductase activity and growth of glutathione-depleted mouse leukemia L 1210 cells invitro. Cancer Lett 1988, 40:257-264.
24. Masnini M. Determination of superoxide dismutase activity with an electrochemical oxygen probe. Analyt Chim Acta 1988, 211:195-204.
25. Shen G.X. Oxidative stress and diabetes cardiovascular disorders: Roles of mitochondria and NADPH oxidase. Can J Physiol Pharmacol 2010, 88:241-248.
26. Ola M.S., Berkich D.A., Xu Y., et al. Analysis of glucose metabolism in diabetes rat retinas. Am J Physiol Endocrinol Metab 2006, 290:E1057-E1067.
27. Uikey A.K., Hazarey V.K., Vaidhya S.M. Estimation of serum antioxidant enzymes superoxide dismutase and glutathione peroxidase in oral submucous fibrosis: A biochemical study. JOral Maxillofac Pathol 2003, 7:44-45.
28. Talaei A., Mohamadi M., Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 2013, 5:1-5.
29. Moussa S.A. Oxidative stress in diabetes mellitus. Romanian J Biophys 2008, 18:225-236.
30. Kumawat M., Pahwa M.B., Gahlaut V.S., et al. Status of antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus with micro vascular complications. Open Endocrinol J 2009, 3:12-15.
31. Kumawat M., Singh I., Singh N., et al. Lipid peroxidation and lipid profile in type 2 diabetes mellitus. Webmed Central Biochem 2012, 3:WMC003147.
32. Bhutia Y., Ghosh A., Sherpa M.L., et al. Serum malondialdehyde level: Surrogate stress marker in the Sikkimese diabetics. JNat Sci Biol Med 2011, 2:107-112.
33. Ho H.Y., Cheng M.L., Chiu D.T.Y. Glucose-6-phosphate dehydrogenase: From oxidative stress to cellular functions and degenerative diseases. Redox Rep 2007, 12:109-118.
34. Xu Y., Osborne B.W., Stanton R.C. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 2005, 289:F1040-F1047.
35. Leopold J.A., Cap A., Scribner A.W., et al. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 2001, 15:1771-1773.
36. Zhang Z., Apse K., Pang J., et al. High Glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. JBiol Chem 2000, 275:40042-40047.
37. Soliman G.Z.A. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetes patients. Singapore J 2008, 49:129-136.
38. Niedowicz D.M., Daleke D.L. The role of oxidative stress in diabetes complications. Cell Biochem Biophys 2005, 43:289-330.
39. Aouacheri W., Saka S., Djafer R., et al. Protective effect of diclofenac towards the oxidative stress induced by paracetamol toxicity in rats. [Effet protecteur du diclofénac contre le stress oxydant induit par la toxicité du paracétamol chez les rats.]. Ann Biol Clin 2009, 67:619-627.
40. Gillery P. Oxidative stress and protein glycation in diabetes mellitus. Ann Biol Clin 2006, 64:309-314.
41. Rahbani-Nobar M.E., Rahimi-Pour A., Rahbani-Nobar M., et al. Total antioxidant capacity, superoxide dismutase and glutathione peroxidase in diabetes patients. Med J Islam Acad Sci 1999, 12:109-114.
42. Hisalkar P.J., Patne A.B., Fawade M.M., et al. Evaluation of plasma superoxide dismutase and glutathione peroxidase in type 2 diabetes patients. Biol Med 2012, 4:65-72.
43. Seghrouchni I., Drai J., Bannier E., et al. Oxidative stress parameters in type 1, type 2 and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 2002, 321:89-96.
44. Kimura F., Hasegawa G., Obayashi H., et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes: Relationship to the development of micro- and macrovascular complications. Diabetes Care 2003, 26:1246-1250.
45. Padalkar R.K., Shinde A.V., Patil S.M. Lipid profile, serum malondialdehyde, superoxide dismutase in chronic kidney diseases and type 2 diabetes mellitus. Biomed Res 2012, 23:207-210.
46. Bandeira S.M., Guedes G.S., Fonseca L.J.S., et al. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: Increase in lipid peroxidation and SOD activity. Oxid Med Cell Longev (Online) 2012, 2012:1-13.
47. Nakhjavani M., Esteghamati A., Nowroozi S., et al. Type 2 diabetes mellitus duration: An independent predictor of serum malondialdehyde levels. Singapore J 2010, 51:582-585.
48. Kassim M.N. Oxidative stress and metabolic control in type 2 diabetes patients. Iraqi Acad Sci J 2011, 24:70-78.
49. Goodarzi M.T., Varmaziar L., Navidi A.A., et al. Study of oxidative stress in type 2 diabetes patients and its relationship with glycated hemoglobin. Saudi J 2008, 29:503-506.
50. Vessby J., Basu S., Mohsen R., et al. Oxidative stress and antioxidant status in type1 diabetes mellitus. JIntern Med 2002, 25:69-76.